Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of anti-tumour cell-mediated immunity

Rashid A. Bhatti, Richard J. Ablin, Patrick D. Guinan

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Tissue- and disease-specificity of the reactivity of peripheral blood leukocytes from 20 prostatic cancer patients to malignant prostatic tissue have been evaluated. Results of leukocyte adherence inhibition, employed previously, had suggested antitumour cell-mediated immunity. Absence of significant reactivity in prostatic cancer patients to tissues other than malignant prostate and in non-prostatic cancer patients (including patients with benign disease of the prostate) to malignant prostate confirms earlier observations. These had suggested the identification of prostatic tumour-associated antigens and of tumour-associated immunity in prostatic carcinoma.

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalEuropean Journal of Cancer (1965)
Volume15
Issue number1
DOIs
StatePublished - Jan 1979
Externally publishedYes

Keywords

  • Cell-Mediated Immunity
  • Leukocyte Adherence Inhibition
  • Prostatic Cancer
  • Tumour-Associated Antigens and Tumour-Associated Immunity

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. II. Tissue- and disease-specificity of anti-tumour cell-mediated immunity'. Together they form a unique fingerprint.

Cite this